National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

octreotide pamoate
A synthetic long-acting octapeptide analogue of endogenous somatostatin. Octreotide pamoate binds to somatostatin receptors expressed by some neuroendocrine and non-neuroendocrine tumor cells, thereby initiating somatostatin receptor-mediated apoptosis. Other possible antineoplastic activities of this agent include suppression of tumor angiogenesis and tumor growth-promoting insulin-like growth factor 1 (IGF-1). Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:octreotide pamoate LAR(SMS 201-995)
OP LAR
US brand names:OncoLAR
Sandostatin pamoate
Sandostatin pamoate LAR
Code names:SMS 201-995 pa
SMS 201-995 pa LAR



Previous:NY-ESO-B, O6-benzylguanine, obatoclax mesylate, oblimersen sodium, octreotide acetate
Next:odanacatib, Oestrogenine, Oestromenin, Oestromon, ofatumumab

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov